Bypass Graft Patency: Which Grafts Last Longest

If you or a family member is facing coronary artery bypass grafting — the operation doctors call CABG — one of the first honest questions to ask is: how long will the grafts actually stay open? Bypass graft patency simply means how well a graft keeps working over the years, and it is the single most important factor in how long the operation protects you. In this guide, we walk through the graft types surgeons choose from, why some last decades while others narrow within a few years, and what you can do after surgery to protect your grafts. Our goal is that by the end, you can sit down with a cardiac team and ask the right questions about your own coronary bypass graft patency.

What Does Bypass Graft Patency Mean?

Patency, in plain words: When a surgeon performs coronary artery bypass grafting, they connect a new piece of blood vessel — a graft — so that blood can flow around a blocked coronary artery, the vessel that feeds your heart muscle. Patency means the graft remains open, with blood flowing freely through it, just like a clear pipe. If a graft loses patency, it narrows or blocks (what doctors call graft occlusion), and the heart muscle beyond it may no longer be protected.

Why patency is the outcome that matters: A bypass operation does not cure the underlying disease; it reroutes blood around the blockages. The benefit of the operation therefore lives or dies with the durability of the grafts. This is why graft patency is studied so carefully in the surgical literature, and why surgeons weigh graft choice so heavily before a multi-vessel bypass graft choice is made.

Patency is usually reported as a percentage of grafts still open at a given time — one year, five years, ten years. These numbers are averages across large groups of patients, and they are influenced by the graft type used, the artery being bypassed, and how well risk factors are controlled afterward. A graft is not a guarantee; it is a chance, and the way you live after surgery changes that chance.

Which Graft Is Better for CABG?

The short answer: There is no single best graft for bypass surgery for everyone — but there is a clear hierarchy surgeons follow. Arterial grafts, which are taken from arteries elsewhere in your body, generally stay open longer than venous grafts, which are taken from veins. The two most common arterial grafts are the internal mammary artery (from inside the chest wall) and the radial artery (from the forearm). The workhorse venous graft is the saphenous vein, taken from the leg.

Here is how the main graft options compare at a glance:

• Left internal mammary artery (LIMA): the gold standard for the most important coronary artery, the left anterior descending; excellent long-term patency.
• Radial artery: an arterial graft with very good durability when used in the right coronary territory and prepared correctly.
• Saphenous vein graft: easy to harvest and versatile for multiple blockages, but more prone to narrowing over the years.
• Right internal mammary artery: another strong arterial option, used selectively in younger patients or total arterial revascularization strategies.

In our team's experience, graft selection is never one-size-fits-all. Every case is reviewed by the multidisciplinary team against international practice guidelines before a recommendation is given, and the patient receives a clear proposal with the alternatives — the final decision is always theirs. In our consultations we show patients their angiogram and explain, in plain words, which vessel could receive which graft and why.

Internal Mammary Artery Graft Patency: Why It Sets the Standard

Why the LIMA lasts so long: The internal mammary artery — usually the left one, called the LIMA — is sewn to the left anterior descending artery, the vessel that supplies a large area of the heart's main pumping chamber. LIMA graft long term patency is exceptional because this artery has a muscular wall that resists the process of atherosclerosis (cholesterol build-up), and it releases natural chemicals that keep it from spasming. Decades of follow-up in the surgical literature show that a large majority of LIMA grafts remain open ten years and beyond, which is one reason this technique is standard practice worldwide.

What happens to the chest wall after: Patients often worry that removing this artery will weaken the chest. In practice, the chest has a network of small collateral vessels that take over the blood supply to the chest wall, and most people notice no long-term difference. The harvesting can be done open or with minimally invasive techniques, which can reduce wound discomfort.

Because the LIMA performs so well, using it has become a quality benchmark in coronary bypass graft durability. In every coronary case we review, the question is not whether to use the internal mammary artery, but how to extend its benefit to the other vessels where the evidence supports it.

Saphenous Vein Graft Patency and How It Changes Over Time

A vein is not an artery: The saphenous vein graft — the long vein on the inner leg — has been used since the earliest days of CABG, and it remains extremely common because one leg provides enough length to bypass several blockages at once. But a vein is built for low pressure, and when placed in the high-pressure arterial system it undergoes changes over time. Understanding saphenous vein graft patency means understanding three phases of graft failure.

The three phases of vein graft failure:

• Early (first month): clot formation within the graft, often related to technical factors or low blood flow through the graft.
• Intermediate (first year): intimal hyperplasia — the vein's inner lining thickens as it reacts to arterial pressure.
• Late (years): atherosclerosis — the same cholesterol disease that blocked the native arteries can develop inside the vein graft.

Because of these changes, saphenous vein graft patency is solid in the first years but declines more than arterial grafts over the long term. Vein graft stenosis — a narrowing inside the graft — is one of the most common reasons a patient returns years later with returning symptoms. When we see a patient with a vein graft from years ago, the first thing we look for on their imaging is whether the graft itself has narrowed, because that changes the whole treatment plan.

Radial Artery Graft Patency and Other Arterial Options

The radial artery explained: The radial artery is the artery you feel at your wrist. Since the 1990s surgeons have used it as a second arterial graft, and radial artery graft patency in appropriately selected patients compares favorably with the internal mammary artery — particularly when the graft is sewn to a coronary artery with a significant blockage, which keeps brisk blood flow through it. The hand normally receives blood through a second artery (the ulnar artery), so the forearm tolerates the removal well, though patients are checked beforehand with a simple test of that collateral circulation.

Right internal mammary and other conduits: The right internal mammary artery can be used to reach arteries on the right side of the heart, contributing to what surgeons call total arterial revascularization — a bypass where every graft is an artery. Some surgeons also use the gastroepiploic artery from the abdomen in selected cases. The goal of total arterial revascularization patency strategies is simple: replace the veins that tend to fail with arteries that tend to last.

There are trade-offs. Harvesting additional arteries takes longer and carries its own small risks, and the benefit is greatest in younger patients expected to live many decades with their grafts. We weigh the patient's age, the quality of the coronary arteries, and the expected decades of benefit before recommending a second arterial graft, and we always present the alternatives.

How Common Is Graft Failure After Coronary Bypass?

The honest numbers: Graft failure after CABG is common enough that every patient should know about it, but rare enough that it should not cause fear. A meaningful minority of vein grafts can close within the first year, most often due to early clot or intermediate thickening, and the rate of failure climbs gradually over the following decades. Arterial grafts fail far less often. These are averages, not personal predictions — a patient's own graft patency depends on the factors discussed in the next section.

What causes a graft to fail: The most frequent culprits are continued smoking, poorly controlled diabetes, high cholesterol, and grafts that carry low blood flow because the artery beyond them was not severely blocked. A well-known finding in the cardiology literature is that grafts connected to arteries that are only moderately narrowed tend to fail early — the graft simply doesn't have enough demand to stay open. Surgeons now often use measurements like fractional flow reserve to confirm that a blockage truly needs bypassing, which improves graft patency rates.

When graft failure causes symptoms: Some grafts close silently, and the heart finds other routes through existing collaterals. Others cause the return of angina (chest pain), shortness of breath, or in some cases a heart attack. This is why surveillance matters, and why any new or changed chest symptoms years after a bypass deserve prompt evaluation. In our practice, any patient who returns with new symptoms after a bypass is worked up promptly, because distinguishing a narrowed graft from progression of native disease changes everything about the treatment.

Off-Pump Bypass Graft Patency: Does Technique Matter?

On-pump versus off-pump: In conventional CABG the heart is stopped and the patient is placed on a heart-lung machine — a process called cardiopulmonary bypass — and the operation is called on-pump bypass. Off-pump bypass means the surgeon operates on the beating heart without the machine. Off-pump was developed to reduce complications from the machine, such as stroke or kidney issues, particularly in older or sicker patients.

What the evidence shows: Early studies raised concerns that operating on a beating heart might make the surgical connections less precise, and some trials suggested lower graft patency with off-pump surgery in less experienced hands. Later research and modern techniques have narrowed this gap, and the outcome depends heavily on the surgeon's experience and how carefully the anastomosis — the surgical connection between graft and coronary artery — is performed. Details like the angle of the distal anastomosis have been studied for their effect on long-term graft patency.

For patients, the practical takeaway is this: the choice between on-pump bypass and off-pump should be made by a team based on your anatomy, your age, and your overall condition — not by ideology. Our team performs both conventional and minimally invasive approaches, and we recommend the less invasive route only where the evidence supports it for that specific patient.

Bypass Graft Occlusion Prevention: What You Can Do

Medications that protect grafts: Bypass graft occlusion prevention starts before you leave the hospital. Every bypass patient should be on antiplatelet therapy — usually aspirin, often with a second agent such as clopidogrel — which prevents the platelets in blood from forming clots inside the graft. Studies consistently show that aspirin therapy improves early vein graft patency. Statins, the cholesterol-lowering drugs, are equally important: they slow the atherosclerosis that eventually damages vein grafts and are standard for virtually all bypass patients.

Quitting smoking is the single biggest factor: If you take one message from this article, make it this one. Smoking accelerates the failure of vein grafts dramatically and is one of the strongest predictors of early graft closure. Patients who quit after surgery protect their grafts in a way no medication can match.

The rest of the prescription is familiar but real: control diabetes and blood pressure, keep LDL cholesterol at guideline targets, exercise regularly as your cardiac rehabilitation team directs, and attend every follow-up. In the consultation we take the time to explain what the studies actually show, in plain words, and to answer every question before any decision — and that includes a frank conversation about what happens after surgery, not just during it.

Bypass Graft Surveillance: How Doctors Check Your Grafts

How grafts are monitored: Bypass graft surveillance can include a stress test (an exercise or imaging test that shows how well the heart muscle is being supplied), a CT coronary angiogram (a scan that can visualize the grafts directly), or a repeat coronary angiogram if symptoms suggest a problem. Not every patient needs routine scanning every year; surveillance is guided by symptoms and by what was found at the time of surgery.

Warning signs that deserve attention: Chest pain similar to your original angina, unusual shortness of breath on exertion, or new fatigue that limits your daily activities are all reasons to contact your cardiac team. These symptoms do not always mean a graft has failed — native disease can also progress — but they always deserve evaluation.

It is worth knowing that opening a graft that has narrowed can sometimes be done without open surgery — a stent can be placed inside the narrowed vein graft in a catheterization procedure. Repeat bypass surgery graft options also exist, including using new arterial grafts or reusing existing grafts, and venous grafts from the arm can be options for peripheral blockages in patients whose disease extends beyond the heart. When imaging shows a narrowed graft, the case should be reviewed carefully before anything is proposed, because the right answer is often the less invasive one.

How Long Do Bypass Grafts Last, and What Comes Next?

Realistic expectations: So, how long do bypass grafts last? The honest answer: an arterial graft such as the internal mammary artery very often serves for decades, and many patients never need anything further from it. A saphenous vein graft typically serves well for years and then, in a portion of patients, narrows or closes later in life. The operation itself is designed to buy you decades — and the most common pattern is not a sudden failure, but a gradual, manageable one.

What a second operation looks like: Redo bypass surgery is more complex than the first operation, because of scar tissue and because the original grafts limit the surgical options. This is why many surgeons now favor doing as much as possible with arterial grafts the first time — a strategy sometimes called the "second-artery" approach — precisely to reduce the chance of a future redo. In our practice we plan each operation with the next ten years in mind, not just the next ten days.

Choosing your team: Because graft selection and surgical technique so strongly influence coronary bypass graft durability, the experience of the team performing the operation matters. Ask your surgeon which grafts they plan to use, why, and what their approach to arterial grafts is. And consider a second opinion — we encourage it and treat seeking one as a normal part of deciding about heart surgery. The first contact is a free video consultation: we get to know the patient, talk through the condition, and say which studies are still needed so no unnecessary ones are ordered.

The takeaway: Graft patency is not a mystery — it is the product of good graft choice, precise surgery, and faithful follow-up care. A LIMA graft is the backbone of modern bypass surgery; arterial grafts extend its reach; vein grafts remain valuable tools when used and protected well. Understand your grafts, protect them aggressively, and stay in touch with your cardiac team for life.